Eyal Rubin

Chief Financial Officer, BRAINSTORM CELL THERAPEUTICS INC.

Companies

Nasus Pharma LtdChief financial officer Mar 27, 2026 to Sep 23, 2026¹
Protalix Biotherapeutics IncChief financial officer Sep 24, 2019 to Nov 5, 2024²
BRAINSTORM CELL THERAPEUTICS INC.Chief financial officer Nov 20, 2017 to Nov 20, 2017³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Protalix Biotherapeutics Inc PLX660,909 shares⁴$1.8M at $2.71Sep 23, 2024

As of each latest filing. The line shows shares held over time.

Recent filings

Sep 23, 2024Granted 99,010 shares of Protalix Biotherapeutics Inc⁵
Sep 23, 2024Granted 90,909 shares of Protalix Biotherapeutics Inc⁴
Aug 15, 2023Granted 201,903 shares of Protalix Biotherapeutics Inc⁶
Feb 25, 2022Granted 121,951 shares of Protalix Biotherapeutics Inc⁷

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARNasus Pharma Ltd, Chief financial officer
2
SEC EDGARProtalix Biotherapeutics Inc, Chief financial officer
3
SEC EDGARBRAINSTORM CELL THERAPEUTICS INC., Chief financial officer
4
SEC EDGARProtalix Biotherapeutics Inc shares after the filing of Sep 23, 2024
5
SEC EDGARForm 4 filed Sep 24, 2024
6
SEC EDGARForm 4 filed Aug 17, 2023
7
SEC EDGARForm 4 filed Feb 28, 2022